Table 1 Molecular analysis of BCC.
From: Human Papillomaviruses, p16INK4a and Akt expression in basal cell carcinoma
Patient | Gender | Age | Phototype Fitzpatrick's Scale | Anatomic site | HPV forehead | HPV lesion | HPV normal skin | p16Ink4alesion | p-Akt lesion | Akt2 lesion |
|---|---|---|---|---|---|---|---|---|---|---|
1 | M | 89 | III | Back | DL231 | HPV 107 | neg | Moderate (1%) | ND | ND |
2 | M | 47 | II | Back | HPV 36 | HPV 38 | neg | Moderate (10%) | ND | ND |
3 | M | 68 | III | Back | DL231 | HPV 99 | neg | Moderate (10%) | neg | neg |
4 | M | 70 | II | Back | HPV 113 | DL231 | neg | Moderate (5%) | positive | neg |
5 | F | 76 | II | Legs | HPV 38 | neg | HPVX14 | Moderate (20%) | positive | neg |
6 | M | 64 | II | Back | HPV 38 | HPV 107 | neg | High (30%) | positive | positive |
7 | F | 76 | III | Legs | HPV 47 | HPV 15 | HPV 38 | High (40%) | positive | positive |
8 | F | 76 | III | Back | HPV 47 | DL473 | HPV 38 | Moderate (15%) | positive | neg |
9 | F | 78 | III | Back | HPV 100 | HPV 8 | HPV 38 | Moderate (10%) | positive | positive |
10 | M | 80 | III | Back | neg | HPV 15 | HPV 15 | High (30%) | positive | neg |
11 | M | 44 | IV | Trunk | HPV 100 | HPV 15 | HPV 15 | High (40%) | positive | positive |
12 | M | 82 | III | Trunk | HPV 98 | HPV 8 | HPV 8 | Moderate (1%) | positive | neg |
13 | F | 37 | III | Trunk | DL314 | HPV 24 | HPV 38 | Moderate (3%) | positive | neg |
14 | F | 61 | IV | Trunk | HPV 100 | HPV 24 | DL314 | Moderate (15%) | positive | positive |
15 | M | 76 | III | Legs | HPV 113 | neg | neg | Moderate (4%) | positive | neg |
16 | M | 56 | III | Trunk | HPV 5 | neg | DL 231 | Moderate (1%) | ND | neg |
17 | M | 58 | III | Head | HPV 15 | neg | neg | Moderate (2%) | ND | neg |
18 | M | 68 | III | Neck | HPV 115 | neg | HPV 38 | Moderate (20%) | positive | positive |
19 | F | 67 | IV | Arms | HPVX14 | HPV 107 | HPV 8 | neg | positive | positive |
20 | M | 71 | II | Trunk | DL267 | neg | neg | ND | positive | neg |
21 | M | 80 | IV | Forehead | HPVX14 | HPV 115 | HPV 113 | Moderate (10%) | positive | positive |
22 | M | 45 | II | Trunk | HPV 15 | HPV 100 | HPV 107 | Moderate (1%) | positive | positive |
23 | F | 40 | III | Arms | HPV 24 | HPV 100 | neg | Moderate (10%) | positive | neg |
24 | F | 50 | II | Back | HPVX14 | HPV 122 | neg | ND | ND | positive |
25 | M | 80 | IV | Trunk | HPV 37 | HPV 107 | neg | Moderate (20%) | positive | positive |
26 | F | 69 | II | Neck | HPV 23 | DL267 | neg | High (30%) | positive | positive |
27 | M | 51 | IV | Legs | DL267 | neg | neg | neg | neg | neg |
28 | M | 61 | IV | Back | neg | neg | neg | High (40%) | positive | positive |
29 | F | 71 | IV | Forehead | HPV 100 | HPV 20 | neg | Moderate (15%) | positive | neg |
30 | M | 45 | IV | Back | neg | HPV 100 | HPVX14 | High (50%) | positive | neg |
31 | M | 39 | II | Back | HPV 100 | HPV 20 | neg | Moderate (5%) | positive | neg |
32 | F | 41 | III | Trunk | HPV 151 | HPVX14 | neg | Moderate (3%) | positive | positive |
33 | F | 60 | III | Back | HPV 38 | neg | DL267 | Moderate (20%) | positive | neg |
34 | F | 69 | III | Back | HPV 38 | neg | neg | Moderate (5%) | positive | neg |
35 | F | 60 | III | Trunk | HPV 38 | neg | DL267 | Moderate (5%) | positive | neg |
36 | M | 39 | II | Back | HPV 100 | HPV 113 | HPVX14 | Moderate (15%) | positive | neg |
37 | F | 40 | III | Arms | HPV 24 | HPV 151 | HPV 107 | High (30%) | positive | neg |